These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

170 related articles for article (PubMed ID: 35494054)

  • 1. The Histone Deacetylase Inhibitor I13 Induces Differentiation of M2, M3 and M5 Subtypes of Acute Myeloid Leukemia Cells and Leukemic Stem-Like Cells.
    Ma X; Zhao M; Wu ZX; Yao J; Zhang L; Wang J; Hu Z; Wei L; Chen ZS
    Front Oncol; 2022; 12():855570. PubMed ID: 35494054
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Histone Deacetylase Inhibitor I3 Induces the Differentiation of Acute Myeloid Leukemia Cells with
    Zhao M; Duan Y; Wang J; Liu Y; Zhao Y; Wang H; Zhang L; Chen ZS; Hu Z; Wei L
    J Oncol; 2022; 2022():3345536. PubMed ID: 36072977
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Jiyuan oridonin A induces differentiation of acute myeloid leukemia cells including leukemic stem-like cells.
    Li F; Gao C; Li X; Wang J; Zhao Y; Ke Y; Liu Y; Liu HM; Hu Z; Wei L; Chen ZS
    Front Pharmacol; 2022; 13():1001552. PubMed ID: 36133825
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Histone Deacetylase Inhibitor I1 Induces Differentiation of Acute Leukemia Cells With MLL Gene Rearrangements
    Yao J; Li G; Cui Z; Chen P; Wang J; Hu Z; Zhang L; Wei L
    Front Pharmacol; 2022; 13():876076. PubMed ID: 35571127
    [TBL] [Abstract][Full Text] [Related]  

  • 5. OGP46 Induces Differentiation of Acute Myeloid Leukemia Cells via Different Optimal Signaling Pathways.
    Zhao M; Wang J; Qu M; Zhao Y; Wang H; Ke Y; Liu Y; Lei ZN; Liu HM; Hu Z; Wei L; Chen ZS
    Front Cell Dev Biol; 2021; 9():652972. PubMed ID: 33748146
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Time- and residue-specific differences in histone acetylation induced by VPA and SAHA in AML1/ETO-positive leukemia cells.
    Barbetti V; Gozzini A; Cheloni G; Marzi I; Fabiani E; Santini V; Dello Sbarba P; Rovida E
    Epigenetics; 2013 Feb; 8(2):210-9. PubMed ID: 23321683
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of anti-CD44 monoclonal antibodies on differentiation and apoptosis of human myeloid leukemia cell lines.
    Charrad RS; Gadhoum Z; Qi J; Glachant A; Allouche M; Jasmin C; Chomienne C; Smadja-Joffe F
    Blood; 2002 Jan; 99(1):290-9. PubMed ID: 11756184
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [ITF-2357 on inhibition myeloid leukemic cell lines cells proliferation in vitro and its mechanism].
    Yu WJ; Wang L; You LS; Mei C; Ma QL; Jin J
    Zhonghua Xue Ye Xue Za Zhi; 2012 May; 33(5):366-70. PubMed ID: 22781793
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Butyrates and decitabine cooperate to induce histone acetylation and granulocytic maturation of t(8;21) acute myeloid leukemia blasts.
    Gozzini A; Santini V
    Ann Hematol; 2005 Dec; 84 Suppl 1():54-60. PubMed ID: 16228241
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Histone deacetylase inhibition improves dendritic cell differentiation of leukemic blasts with AML1-containing fusion proteins.
    Moldenhauer A; Frank RC; Pinilla-Ibarz J; Holland G; Boccuni P; Scheinberg DA; Salama A; Seeger K; Moore MA; Nimer SD
    J Leukoc Biol; 2004 Sep; 76(3):623-33. PubMed ID: 15197237
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of anti-CD44 monoclonal antibodies on differentiation and proliferation of human acute myeloid leukemia cells.
    Gadhoum Z; Delaunay J; Maquarre E; Durand L; Lancereaux V; Qi J; Robert-Lezenes J; Chomienne C; Smadja-Joffe F
    Leuk Lymphoma; 2004 Aug; 45(8):1501-10. PubMed ID: 15370200
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Oroxylin A, a natural anticancer flavonoid compound, induces differentiation of t(8;21)-positive Kasumi-1 and primary acute myeloid leukemia cells.
    Hui H; Zhang X; Li H; Liu X; Shen L; Zhu Y; Xu J; Guo Q; Lu N
    J Cancer Res Clin Oncol; 2016 Jul; 142(7):1449-59. PubMed ID: 27085528
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The Class IIA Histone Deacetylase (HDAC) Inhibitor TMP269 Downregulates Ribosomal Proteins and Has Anti-Proliferative and Pro-Apoptotic Effects on AML Cells.
    Urwanisch L; Unger MS; Sieberer H; Dang HH; Neuper T; Regl C; Vetter J; Schaller S; Winkler SM; Kerschbamer E; Weichenberger CX; Krenn PW; Luciano M; Pleyer L; Greil R; Huber CG; Aberger F; Horejs-Hoeck J
    Cancers (Basel); 2023 Feb; 15(4):. PubMed ID: 36831382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of leukemic cells by valproic acid, an HDAC inhibitor, in xenograft tumors.
    Zhang Z; Hao C; Wang L; Liu P; Zhao L; Zhu C; Tian X
    Onco Targets Ther; 2013; 6():733-40. PubMed ID: 23836985
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Apicidin confers promising therapeutic effect on acute myeloid leukemia cells via increasing QPCT expression.
    Liu L; Liu H; Liu L; Huang Q; Yang C; Cheng P; Ren S; Zhang J; Yu M; Ma X; Song W; Chen L; Zhang H; Chen M; Zhang X
    Cancer Biol Ther; 2023 Dec; 24(1):2228497. PubMed ID: 37381175
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Radotinib inhibits acute myeloid leukemia cell proliferation via induction of mitochondrial-dependent apoptosis and CDK inhibitors.
    Heo SK; Noh EK; Gwon GD; Kim JY; Jo JC; Choi Y; Koh S; Baek JH; Min YJ; Kim H
    Eur J Pharmacol; 2016 Oct; 789():280-290. PubMed ID: 27477352
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic drug screen identifies the histone deacetylase inhibitor NSC3852 as a potential novel drug for the treatment of pediatric acute myeloid leukemia.
    Wiggers CRM; Govers AMAP; Lelieveld D; Egan DA; Zwaan CM; Sonneveld E; Coffer PJ; Bartels M
    Pediatr Blood Cancer; 2019 Aug; 66(8):e27785. PubMed ID: 31044544
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cooperative effect of chidamide and chemotherapeutic drugs induce apoptosis by DNA damage accumulation and repair defects in acute myeloid leukemia stem and progenitor cells.
    Li Y; Wang Y; Zhou Y; Li J; Chen K; Zhang L; Deng M; Deng S; Li P; Xu B
    Clin Epigenetics; 2017; 9():83. PubMed ID: 28814980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of chidamide and its combination with decitabine on proliferation and apoptosis of leukemia cell lines.
    Mao J; Li S; Zhao H; Zhu Y; Hong M; Zhu H; Qian S; Li J
    Am J Transl Res; 2018; 10(8):2567-2578. PubMed ID: 30210693
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anticoagulant effects of retinoic acids on leukemia cells.
    Saito T; Koyama T; Nagata K; Kamiyama R; Hirosawa S
    Blood; 1996 Jan; 87(2):657-65. PubMed ID: 8555488
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.